COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Joseph Mosca

Dr. Joseph Mosca

Scientific Review Officer


Division of Basic and Integrative Biological Sciences DBIB
Bioengineering Sciences and Technologies BST
Study Section:
Biomaterials and Biointerfaces BMBI

Dr. Mosca’s career in academia and biotechnology spans over 20 years as a researcher, manager, and officer of two start-up biotech companies.

Joe received his Ph.D. in biochemistry at Temple University, completed a post-doctoral fellowship in oncology at Johns Hopkins, and earned a MBA degree from Johns Hopkins Business. After spending 7 years at Hopkins with assistant professorships in oncology and infectious diseases, he joined the H.M. Jackson Foundation, where he continued his gene therapy efforts in HIV/AIDS. In 1996, he moved from academia to industrial research in tissue regeneration in adult and embryonic stem cells. In 2001, he founded his own technology-holding company and in 2002 was vice president of development for an international HIV vaccine company. He has authored over 50 peer-reviewed manuscripts, 9 book chapters, and is inventor on 7 US issued patents with 10 pending approval.